Compare Sun Pharma with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ELDER PHARMA - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA ELDER PHARMA SUN PHARMA/
ELDER PHARMA
 
P/E (TTM) x 22.3 -0.2 - View Chart
P/BV x 2.6 0.1 2,590.9% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUN PHARMA   ELDER PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
ELDER PHARMA
Jun-14
SUN PHARMA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs679380 178.6%   
Low Rs375188 199.7%   
Sales per share (Unadj.) Rs121.1491.2 24.7%  
Earnings per share (Unadj.) Rs13.4-3.2 -420.4%  
Cash flow per share (Unadj.) Rs20.714.4 143.6%  
Dividends per share (Unadj.) Rs2.750-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs172.6376.5 45.8%  
Shares outstanding (eoy) m2,399.2620.54 11,680.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.40.6 752.5%   
Avg P/E ratio x39.4-89.3 -44.1%  
P/CF ratio (eoy) x25.519.7 129.3%  
Price / Book Value ratio x3.10.8 404.9%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m1,264,6505,833 21,679.6%   
No. of employees `00017.5NA-   
Total wages/salary Rs m59,6712,179 2,738.5%   
Avg. sales/employee Rs Th16,608.1NM-  
Avg. wages/employee Rs Th3,409.6NM-  
Avg. net profit/employee Rs Th1,833.8NM-  
INCOME DATA
Net Sales Rs m290,65910,089 2,880.9%  
Other income Rs m10,255257 3,996.5%   
Total revenues Rs m300,91410,346 2,908.6%   
Gross profit Rs m63,076-792 -7,965.1%  
Depreciation Rs m17,533361 4,852.6%   
Interest Rs m5,5532,756 201.4%   
Profit before tax Rs m50,246-3,653 -1,375.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,1443,713 -327.1%   
Tax Rs m6,009125 4,801.3%   
Profit after tax Rs m32,093-65 -49,109.7%  
Gross profit margin %21.7-7.8 -276.5%  
Effective tax rate %12.0-3.4 -349.1%   
Net profit margin %11.0-0.6 -1,704.6%  
BALANCE SHEET DATA
Current assets Rs m310,6929,240 3,362.5%   
Current liabilities Rs m173,3969,998 1,734.4%   
Net working cap to sales %47.2-7.5 -629.0%  
Current ratio x1.80.9 193.9%  
Inventory Days Days9946 213.9%  
Debtors Days Days11260 186.1%  
Net fixed assets Rs m232,47710,124 2,296.4%   
Share capital Rs m2,399206 1,166.4%   
"Free" reserves Rs m411,6915,582 7,374.9%   
Net worth Rs m414,0917,734 5,354.5%   
Long term debt Rs m15,2264,889 311.4%   
Total assets Rs m646,93822,882 2,827.3%  
Interest coverage x10.0-0.3 -3,089.3%   
Debt to equity ratio x00.6 5.8%  
Sales to assets ratio x0.40.4 101.9%   
Return on assets %5.811.8 49.5%  
Return on equity %7.8-0.8 -917.2%  
Return on capital %10.222.3 45.6%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m66,025307 21,534.7%   
Fx outflow Rs m38,610125 30,814.2%   
Net fx Rs m27,415181 15,121.5%   
CASH FLOW
From Operations Rs m21,96511,754 186.9%  
From Investments Rs m-6,813-561 1,215.4%  
From Financial Activity Rs m-27,305-6,762 403.8%  
Net Cashflow Rs m-8,4424,432 -190.5%  

Share Holding

Indian Promoters % 63.7 39.6 160.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 7.5 68.4%  
FIIs % 23.0 16.8 136.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 36.1 23.0%  
Shareholders   133,026 16,479 807.2%  
Pledged promoter(s) holding % 0.5 77.6 0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare SUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 271 Points Higher; Capital Goods and Realty Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours today and ended higher. Benchmark indices regained momentum amid huge buying seen in capital goods and realty stocks.

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jan 23, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - SUVEN LIFESCIENCES COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS